Journal article icon

Journal article

Clinical presentation, management, and outcome of suspected central nervous system infections in Indonesia: a prospective cohort study

Abstract:
Background: Toxoplasmic encephalitis is a severe manifestation of Toxoplasma gondii infection, with potentially fatal outcomes, particularly among immunocompromised patients. Clinical manifestation of this infection is associated with a specific genotype of T. gondii, requiring the use of genetic marker for genotype determination. Aims: This study critically evaluated the application of GRA6 gene as genetic marker for genotyping T. gondii in cerebrospinal fluid (CSF) samples from HIV/AIDS patients diagnosed with Toxoplasmic encephalitis. Methods: The study analyzed 69 CSF samples from HIV/AIDS patients with Toxoplasmic encephalitis. These samples tested positive for Toxoplasma IgG serology and SAG2 PCR, while GRA6 genotyping was conducted using PCR-sequencing methods. Results: The results showed that GRA6 had potential for genotyping in positive control settings from culture cells. However, there was limited effectiveness in CSF samples from Toxoplasmic encephalitis patients. Conclusion: GRA6 had been proven effective as a genetic marker for the identification of T. gondii genotype among HIV/AIDS patients with Toxoplasmic encephalitis. However, the evaluation of GRA6 showed more effectiveness in cultured cells compared to direct clinical samples, such as cerebrospinal fluid obtained from HIV/AIDS patients with Toxoplasmic encephalitis.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1007/s15010-023-02170-0

Authors

More by this author
Role:
Author
ORCID:
0000-0003-2777-7015
More by this author
Role:
Author
ORCID:
0000-0001-9909-4171
More by this author
Role:
Author
ORCID:
0000-0002-0290-2759
More by this author
Role:
Author
ORCID:
0000-0002-4109-4192
More by this author
Role:
Author
ORCID:
0000-0003-1982-8716


More from this funder
Funder identifier:
10.13039/501100000265
Grant:
MR/S004963/1
More from this funder
Funder identifier:
10.13039/100000002
Grant:
R01AI145781


Publisher:
Springer
Journal:
Infection More from this journal
Volume:
52
Issue:
2
Pages:
583-595
Publication date:
2024-02-05
DOI:
EISSN:
1439-0973
ISSN:
0300-8126


Language:
English
Keywords:
Pubs id:
1620626
Local pid:
pubs:1620626
Source identifiers:
W4391531684
Deposit date:
2026-06-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP